• Skip to main content
  • Skip to footer

EydisBio

  • About Us
  • Technology
    • Pipeline
  • Therapeutic indications
    • Rheumatoid Arthritis
    • Chronic Pain
    • COVID-19 ARDS
  • Our Team
  • Resources
    • Publications & Press Releases
    • FCOI
    • Partners & Funders
  • Contact

Chronic Pain

Delivering novel non-opioid based analgesics

Chronic Pain

Millions of people suffer from chronic pain syndromes each year

Chronic pain is a prevalent health concern, affecting up to 100 million people and carrying an economic burden up to $560 billion annually in the US alone, yet treatment options remain limited. Over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) are short-acting and fail to alleviate severe chronic pain and carry serious safety concerns regarding gastrointestinal events. The more recently improved COX-2 inhibitors (e.g., Celebrex) also carry serious safety concerns such as serious risks of heart attack and stroke. Similarly, longer-acting centrally-targeted therapies such as opioids generally have poor efficacy and produce serious side effects regarding altered mental state, high risk of addiction, and respiratory depression. Thus, there is a high unmet need for alternatives to current treatment options for patients suffering with chronic pain.

How our technology can be applied

TAK1 as a central mediator in chronic pain

One of the main drivers of chronic neuropathic pain is inflammation following tissue injury or nerve injury caused by increased levels of cytokines such as tumor necrosis factor α (TNF), and a positive correlation exists between TNF levels and pain intensity. TNF can bind to its TNFR1 receptor located on the terminals of primary afferent nociceptors to directly increase their activity, and can also stimulate pro-inflammatory cytokine production and immune cell activation.

Our preclinical work has identified TGFβ-activated kinase 1 (TAK1) as a key signaling element in the TNF-mediated pro-pain response pathway. TAK1 plays a crucial role in facilitating activation of protein kinase-mediated signaling pathways implicated in the pathogenesis of chronic pain processes, and as a result has emerged as a novel target for regulating chronic pain and inflammation linked to enhanced TNF signaling. TAK1 plays a crucial role in facilitating activation of protein kinase-mediated signaling pathways implicated in the pathogenesis of chronic pain processes, and as a result has emerged as a novel target for regulating chronic pain and inflammation linked to enhanced TNF signaling. Our technology platform has discovered a highly potent selective inhibitor of TAK1 (EYD-001) for the treatment of chronic pain syndromes.

Graph of Mechanical Alloydnia

Figure 1. Compared to mice receiving vehicle, those receiving TAK1 inhibitor established reduced mechanical sensitivity following CFA induction.

Learn more

Benefits of Our
Application

TAK1 targets inflammation
underlying chronic pain syndromes

TAK1 inhibition reduces
cytokine-induced nociceptor activity

Non-opioid based targeted
therapy for the treatment of pain

Additional information and resources

Our Technology

First selective orally bioavailable inhibitors of TAK1 for the treatment of Chronic Pain

Discover our technology

Our Company

EydisBio is a small biotech located in Durham, North Carolina. Originally created as a spinout of Duke University, EydisBio has gone on to become a leader for the development of selective and potent small molecule inhibitors of disease relevant kinases.

Learn more about us

Our Team

Our team is composed of experienced pharmacologists, chemists, and biologists who leverage their years of industry experience to advance small molecule inhibitors into clinics.

Meet our team

EydisBio

201 W. Main Street, Suite #317
Durham, NC 27701

Footer Office Img

Get Directions

"*" indicates required fields

GDPR Consent*
This field is for validation purposes and should be left unchanged.

Footer Logo

201 W Main Street, Suite #317, Durham, NC, 27701
Privacy Policy | Web Accessibility. Design by TinyFrog Technologies

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits.
By clicking “Accept”, you consent to the use of ALL the cookies. AcceptReject
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT